Advanced Accelerator Applications

This phase 3 study tested whether the drug Lutathera, combined with a long-acting hormone therapy (octreotide), can delay tumor growth in people with advanced neuroendocrine tumors of the stomach, intestines, or pancreas. The trial enrolled 226 patients with fast-growing tumors (…

This study looks at how safe a radioactive drug called Lutathera is for teenagers aged 12 to 18 with certain rare tumors of the gut or adrenal glands. The goal is to measure radiation doses to organs and track side effects. Lutathera is not a cure; it aims to control tumor growth…

This study looks at the long-term safety of Lutathera, a treatment for advanced neuroendocrine tumors that cannot be removed by surgery or have spread. Over 1,000 adults who have already received Lutathera are being followed to track any new cancers, side effects, and overall sur…